Open | - |
Close | - |
Volume / Avg. | 1.129K / 1.055M |
Day Range | - - - |
52 Wk Range | 6.395 - 39.270 |
Market Cap | $2.443B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 69 |
Short Interest | 10.03% |
Days to Cover | 3.69 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alpine Immune Sciences (NASDAQ: ALPN) through any online brokerage.
Other companies in Alpine Immune Sciences’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), TG Therapeutics (NASDAQ:TGTX), PTC Therapeutics (NASDAQ:PTCT) and Dyne Therapeutics (NASDAQ:DYN).
The latest price target for Alpine Immune Sciences (NASDAQ: ALPN) was reported by Wedbush on Tuesday, March 19, 2024. The analyst firm set a price target for 47.00 expecting ALPN to rise to within 12 months (a possible 26.07% upside). 22 analyst firms have reported ratings in the last year.
The stock price for Alpine Immune Sciences (NASDAQ: ALPN) is $37.28 last updated Today at March 19, 2024 at 9:26 AM EDT.
There are no upcoming dividends for Alpine Immune Sciences.
Alpine Immune Sciences’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Alpine Immune Sciences.
Alpine Immune Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.